C. Lowry Barnes
Concepts (404)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthroplasty, Replacement, Knee | 50 | 2022 | 282 | 12.770 |
Why?
| Arthroplasty, Replacement, Hip | 44 | 2022 | 251 | 12.570 |
Why?
| Orthopedics | 10 | 2022 | 54 | 2.680 |
Why?
| Osteoarthritis, Knee | 11 | 2022 | 105 | 2.490 |
Why?
| Health Literacy | 5 | 2019 | 141 | 2.180 |
Why?
| Length of Stay | 16 | 2022 | 683 | 1.970 |
Why?
| Coronavirus Infections | 8 | 2021 | 192 | 1.890 |
Why?
| Pneumonia, Viral | 7 | 2020 | 184 | 1.880 |
Why?
| Arthroplasty, Replacement | 5 | 2019 | 31 | 1.860 |
Why?
| Hip Prosthesis | 6 | 2021 | 73 | 1.850 |
Why?
| Antibodies, Neutralizing | 10 | 2023 | 75 | 1.780 |
Why?
| Preoperative Care | 5 | 2018 | 184 | 1.750 |
Why?
| Patient Readmission | 11 | 2022 | 242 | 1.710 |
Why?
| Medicare | 15 | 2022 | 241 | 1.640 |
Why?
| Aged | 47 | 2022 | 10054 | 1.640 |
Why?
| Humans | 119 | 2023 | 54284 | 1.610 |
Why?
| Knee Joint | 15 | 2022 | 177 | 1.590 |
Why?
| Analgesics, Opioid | 8 | 2022 | 501 | 1.550 |
Why?
| Reoperation | 9 | 2022 | 454 | 1.490 |
Why?
| Antibodies, Viral | 10 | 2023 | 124 | 1.470 |
Why?
| Pandemics | 11 | 2022 | 579 | 1.430 |
Why?
| Retrospective Studies | 36 | 2022 | 6432 | 1.430 |
Why?
| United States | 24 | 2022 | 5217 | 1.350 |
Why?
| Joint Diseases | 3 | 2018 | 43 | 1.320 |
Why?
| Postoperative Complications | 11 | 2022 | 1033 | 1.310 |
Why?
| Critical Pathways | 3 | 2017 | 36 | 1.280 |
Why?
| Range of Motion, Articular | 8 | 2022 | 165 | 1.270 |
Why?
| Hip Dislocation | 2 | 2019 | 17 | 1.240 |
Why?
| Periprosthetic Fractures | 3 | 2021 | 12 | 1.230 |
Why?
| Pain, Postoperative | 5 | 2022 | 161 | 1.230 |
Why?
| Patient Discharge | 13 | 2022 | 353 | 1.210 |
Why?
| Orthopedic Procedures | 6 | 2020 | 82 | 1.200 |
Why?
| Patient Education as Topic | 4 | 2018 | 313 | 1.170 |
Why?
| Comprehension | 2 | 2018 | 115 | 1.160 |
Why?
| Prosthesis Failure | 5 | 2020 | 113 | 1.050 |
Why?
| Middle Aged | 36 | 2022 | 13088 | 1.020 |
Why?
| Pain Management | 3 | 2016 | 155 | 1.000 |
Why?
| Joint Instability | 2 | 2022 | 59 | 0.980 |
Why?
| Prosthesis-Related Infections | 4 | 2021 | 111 | 0.920 |
Why?
| Hip | 2 | 2020 | 26 | 0.910 |
Why?
| Lordosis | 1 | 2022 | 5 | 0.870 |
Why?
| Risk Factors | 17 | 2023 | 3935 | 0.860 |
Why?
| Prosthesis Design | 4 | 2021 | 262 | 0.860 |
Why?
| Kyphosis | 1 | 2022 | 17 | 0.850 |
Why?
| Male | 48 | 2022 | 27334 | 0.850 |
Why?
| Immunoglobulin G | 4 | 2021 | 226 | 0.850 |
Why?
| Knee | 3 | 2021 | 27 | 0.840 |
Why?
| Air Pollution, Indoor | 4 | 2014 | 28 | 0.820 |
Why?
| Transurethral Resection of Prostate | 1 | 2021 | 10 | 0.790 |
Why?
| Blood Transfusion | 3 | 2016 | 138 | 0.780 |
Why?
| Prostatic Hyperplasia | 1 | 2021 | 44 | 0.770 |
Why?
| Immunoglobulin Fab Fragments | 1 | 2020 | 21 | 0.760 |
Why?
| Female | 42 | 2022 | 28441 | 0.730 |
Why?
| Opioid-Related Disorders | 4 | 2022 | 367 | 0.710 |
Why?
| Housing | 3 | 2015 | 48 | 0.700 |
Why?
| Surgery Department, Hospital | 1 | 2019 | 6 | 0.690 |
Why?
| Bone Cements | 1 | 2019 | 33 | 0.680 |
Why?
| Diabetic Foot | 1 | 2019 | 51 | 0.680 |
Why?
| Polymethyl Methacrylate | 1 | 2019 | 28 | 0.680 |
Why?
| Societies, Medical | 2 | 2020 | 194 | 0.670 |
Why?
| Hip Joint | 2 | 2020 | 66 | 0.670 |
Why?
| Cost Savings | 2 | 2017 | 67 | 0.650 |
Why?
| Aged, 80 and over | 12 | 2020 | 3431 | 0.650 |
Why?
| Comorbidity | 5 | 2018 | 663 | 0.640 |
Why?
| Allergens | 4 | 2016 | 144 | 0.640 |
Why?
| Yoga | 1 | 2018 | 21 | 0.630 |
Why?
| Fungi | 3 | 2008 | 48 | 0.630 |
Why?
| Hospitals, Teaching | 2 | 2019 | 58 | 0.610 |
Why?
| Inpatients | 7 | 2020 | 204 | 0.600 |
Why?
| Dust | 2 | 2015 | 25 | 0.590 |
Why?
| Clinical Protocols | 1 | 2017 | 122 | 0.590 |
Why?
| Postoperative Period | 6 | 2018 | 189 | 0.590 |
Why?
| Arthroplasty | 3 | 2023 | 30 | 0.590 |
Why?
| Patient Navigation | 1 | 2016 | 13 | 0.580 |
Why?
| Quadriceps Muscle | 4 | 2022 | 49 | 0.580 |
Why?
| Antifibrinolytic Agents | 1 | 2016 | 18 | 0.570 |
Why?
| Tranexamic Acid | 1 | 2016 | 17 | 0.560 |
Why?
| Osteoarthritis | 4 | 2022 | 71 | 0.560 |
Why?
| Early Ambulation | 1 | 2016 | 6 | 0.560 |
Why?
| Musculoskeletal Pain | 1 | 2016 | 10 | 0.550 |
Why?
| Caregivers | 1 | 2018 | 241 | 0.540 |
Why?
| Knee Prosthesis | 3 | 2021 | 56 | 0.530 |
Why?
| Publishing | 1 | 2016 | 45 | 0.530 |
Why?
| Quality of Health Care | 1 | 2017 | 222 | 0.520 |
Why?
| Periodicals as Topic | 1 | 2016 | 65 | 0.510 |
Why?
| Analgesia, Epidural | 1 | 2015 | 26 | 0.510 |
Why?
| Bupivacaine | 1 | 2015 | 28 | 0.510 |
Why?
| Intermittent Pneumatic Compression Devices | 1 | 2014 | 3 | 0.490 |
Why?
| Narcotics | 3 | 2020 | 107 | 0.490 |
Why?
| Hospitals | 7 | 2022 | 188 | 0.480 |
Why?
| Anti-Bacterial Agents | 2 | 2020 | 820 | 0.470 |
Why?
| Epilepsy | 1 | 2016 | 190 | 0.470 |
Why?
| Anesthesia, General | 3 | 2020 | 96 | 0.470 |
Why?
| Exercise | 1 | 2018 | 552 | 0.460 |
Why?
| Venous Thromboembolism | 1 | 2014 | 75 | 0.440 |
Why?
| Adult | 21 | 2021 | 14207 | 0.440 |
Why?
| Air Pollutants | 1 | 2013 | 70 | 0.430 |
Why?
| Health Expenditures | 3 | 2017 | 67 | 0.420 |
Why?
| Odds Ratio | 7 | 2019 | 604 | 0.410 |
Why?
| Epitopes | 5 | 2023 | 89 | 0.390 |
Why?
| Treatment Outcome | 7 | 2020 | 5604 | 0.370 |
Why?
| Arthritis, Infectious | 2 | 2021 | 42 | 0.370 |
Why?
| Acetabulum | 3 | 2020 | 36 | 0.360 |
Why?
| Asthma | 4 | 2015 | 293 | 0.360 |
Why?
| Models, Molecular | 5 | 2021 | 423 | 0.350 |
Why?
| Golf | 2 | 2019 | 13 | 0.350 |
Why?
| Tibial Fractures | 2 | 2021 | 34 | 0.340 |
Why?
| Osteoarthritis, Hip | 3 | 2019 | 28 | 0.340 |
Why?
| Cryoelectron Microscopy | 4 | 2021 | 10 | 0.340 |
Why?
| Cost-Benefit Analysis | 3 | 2021 | 291 | 0.340 |
Why?
| Fee-for-Service Plans | 2 | 2020 | 11 | 0.340 |
Why?
| Cross-Sectional Studies | 5 | 2016 | 1693 | 0.330 |
Why?
| B-Lymphocytes | 4 | 2021 | 176 | 0.320 |
Why?
| Viscosupplements | 2 | 2017 | 12 | 0.310 |
Why?
| Movement | 4 | 2021 | 111 | 0.310 |
Why?
| Neutralization Tests | 6 | 2023 | 33 | 0.310 |
Why?
| Humidity | 1 | 2007 | 7 | 0.310 |
Why?
| Respiratory Hypersensitivity | 1 | 2007 | 18 | 0.300 |
Why?
| Patient Satisfaction | 2 | 2020 | 304 | 0.300 |
Why?
| Hyaluronic Acid | 2 | 2017 | 32 | 0.300 |
Why?
| Respiratory Tract Diseases | 1 | 2007 | 29 | 0.300 |
Why?
| Risk | 2 | 2017 | 343 | 0.270 |
Why?
| Muscle Strength | 3 | 2022 | 132 | 0.260 |
Why?
| Young Adult | 8 | 2021 | 4318 | 0.250 |
Why?
| Logistic Models | 3 | 2016 | 995 | 0.250 |
Why?
| Mutation | 5 | 2021 | 1501 | 0.250 |
Why?
| Arthralgia | 3 | 2022 | 50 | 0.250 |
Why?
| Public Opinion | 2 | 2021 | 20 | 0.240 |
Why?
| Cross Reactions | 2 | 2021 | 56 | 0.240 |
Why?
| Hospital Mortality | 2 | 2016 | 465 | 0.230 |
Why?
| Femur | 2 | 2021 | 144 | 0.230 |
Why?
| Poverty | 2 | 2015 | 231 | 0.230 |
Why?
| Reproducibility of Results | 3 | 2022 | 1304 | 0.220 |
Why?
| Braces | 1 | 2002 | 10 | 0.220 |
Why?
| Adolescent | 9 | 2021 | 6897 | 0.210 |
Why?
| Myositis | 1 | 2022 | 18 | 0.210 |
Why?
| Pain Measurement | 3 | 2019 | 246 | 0.210 |
Why?
| Outpatients | 2 | 2020 | 123 | 0.210 |
Why?
| Pain | 2 | 2022 | 405 | 0.210 |
Why?
| Gait | 2 | 2021 | 98 | 0.210 |
Why?
| Antibodies, Monoclonal | 6 | 2021 | 562 | 0.210 |
Why?
| Pelvis | 1 | 2022 | 76 | 0.210 |
Why?
| Injections, Intra-Articular | 3 | 2017 | 34 | 0.210 |
Why?
| Databases, Factual | 4 | 2019 | 684 | 0.210 |
Why?
| Antibody Affinity | 1 | 2021 | 11 | 0.210 |
Why?
| Metal-on-Metal Joint Prostheses | 1 | 2021 | 5 | 0.200 |
Why?
| Activities of Daily Living | 2 | 2021 | 204 | 0.200 |
Why?
| Cost of Illness | 1 | 2022 | 133 | 0.200 |
Why?
| Lumbar Vertebrae | 1 | 2022 | 105 | 0.200 |
Why?
| Crowdsourcing | 1 | 2021 | 8 | 0.200 |
Why?
| Vaccines, Synthetic | 1 | 2021 | 24 | 0.200 |
Why?
| Radiography | 5 | 2019 | 524 | 0.200 |
Why?
| Immunity, Humoral | 1 | 2021 | 25 | 0.190 |
Why?
| Receptors, Virus | 1 | 2020 | 30 | 0.190 |
Why?
| Multiple Myeloma | 1 | 2016 | 3035 | 0.190 |
Why?
| Femur Head Necrosis | 1 | 2020 | 17 | 0.190 |
Why?
| Dissociative Disorders | 1 | 2020 | 6 | 0.190 |
Why?
| Joints | 2 | 2018 | 29 | 0.190 |
Why?
| Epitope Mapping | 1 | 2020 | 12 | 0.190 |
Why?
| Adrenal Cortex Hormones | 2 | 2020 | 95 | 0.190 |
Why?
| Polyethylene | 1 | 2020 | 18 | 0.190 |
Why?
| Decompression, Surgical | 1 | 2020 | 52 | 0.190 |
Why?
| Osteonecrosis | 1 | 2020 | 36 | 0.190 |
Why?
| Posture | 1 | 2021 | 80 | 0.190 |
Why?
| Immunization, Passive | 1 | 2020 | 35 | 0.190 |
Why?
| Bariatric Surgery | 1 | 2021 | 43 | 0.190 |
Why?
| Diagnosis-Related Groups | 2 | 2017 | 23 | 0.190 |
Why?
| Obesity, Morbid | 1 | 2021 | 88 | 0.180 |
Why?
| Host-Pathogen Interactions | 1 | 2021 | 143 | 0.180 |
Why?
| External Fixators | 1 | 2019 | 8 | 0.180 |
Why?
| Foot Orthoses | 1 | 2019 | 7 | 0.180 |
Why?
| Tobramycin | 1 | 2019 | 14 | 0.170 |
Why?
| Fracture Healing | 2 | 1996 | 26 | 0.170 |
Why?
| After-Hours Care | 1 | 2019 | 11 | 0.170 |
Why?
| Antiviral Agents | 1 | 2020 | 188 | 0.170 |
Why?
| Hematologic Neoplasms | 1 | 2020 | 99 | 0.170 |
Why?
| Nanoparticles | 1 | 2021 | 173 | 0.170 |
Why?
| Prostheses and Implants | 1 | 2019 | 61 | 0.170 |
Why?
| Recombinant Proteins | 1 | 2020 | 569 | 0.170 |
Why?
| Hospitals, University | 1 | 2019 | 89 | 0.170 |
Why?
| Postural Balance | 2 | 2021 | 61 | 0.170 |
Why?
| Ambulatory Surgical Procedures | 1 | 2019 | 52 | 0.170 |
Why?
| Healthcare Disparities | 1 | 2022 | 271 | 0.160 |
Why?
| Sepsis | 1 | 2021 | 251 | 0.160 |
Why?
| Multiple Sclerosis | 1 | 2019 | 72 | 0.160 |
Why?
| Vancomycin | 1 | 2019 | 88 | 0.160 |
Why?
| Exercise Test | 1 | 2019 | 151 | 0.160 |
Why?
| Drug Prescriptions | 1 | 2019 | 89 | 0.160 |
Why?
| Rural Population | 1 | 2023 | 600 | 0.160 |
Why?
| Recreation | 1 | 2018 | 21 | 0.160 |
Why?
| Lower Extremity | 2 | 2019 | 103 | 0.160 |
Why?
| Microbial Sensitivity Tests | 1 | 2019 | 290 | 0.160 |
Why?
| Medicaid | 2 | 2022 | 267 | 0.160 |
Why?
| Rotation | 1 | 2018 | 76 | 0.160 |
Why?
| Tramadol | 1 | 2018 | 29 | 0.160 |
Why?
| Benzodiazepines | 1 | 2018 | 72 | 0.160 |
Why?
| Guidelines as Topic | 1 | 2018 | 125 | 0.150 |
Why?
| Subacute Care | 1 | 2017 | 4 | 0.150 |
Why?
| Body Mass Index | 2 | 2018 | 713 | 0.150 |
Why?
| Incidence | 3 | 2019 | 1082 | 0.150 |
Why?
| Academic Medical Centers | 1 | 2018 | 141 | 0.150 |
Why?
| Recovery of Function | 1 | 2018 | 222 | 0.150 |
Why?
| Immunologic Memory | 3 | 2021 | 32 | 0.150 |
Why?
| Nut Hypersensitivity | 1 | 2016 | 3 | 0.150 |
Why?
| Fractures, Open | 1 | 1996 | 8 | 0.150 |
Why?
| Language | 1 | 2018 | 138 | 0.150 |
Why?
| Cocos | 1 | 2016 | 3 | 0.150 |
Why?
| Fractures, Bone | 4 | 1992 | 119 | 0.150 |
Why?
| Nuts | 1 | 2016 | 10 | 0.150 |
Why?
| Patient Safety | 1 | 2017 | 121 | 0.140 |
Why?
| Football | 1 | 2018 | 84 | 0.140 |
Why?
| Hospitals, Community | 1 | 2016 | 21 | 0.140 |
Why?
| Costs and Cost Analysis | 1 | 2016 | 109 | 0.140 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 314 | 0.140 |
Why?
| Anesthesia, Spinal | 1 | 2016 | 16 | 0.140 |
Why?
| Peer Review, Research | 1 | 2016 | 13 | 0.140 |
Why?
| Anesthesia, Conduction | 1 | 2016 | 16 | 0.140 |
Why?
| Time Factors | 5 | 2021 | 3213 | 0.140 |
Why?
| Social Support | 1 | 2018 | 299 | 0.140 |
Why?
| Hypersensitivity | 2 | 2008 | 82 | 0.140 |
Why?
| Hemoglobins | 1 | 2016 | 126 | 0.140 |
Why?
| Congresses as Topic | 1 | 2016 | 52 | 0.140 |
Why?
| Prescription Drug Misuse | 1 | 2016 | 30 | 0.130 |
Why?
| Quality Improvement | 1 | 2018 | 245 | 0.130 |
Why?
| Hyperalgesia | 1 | 2016 | 56 | 0.130 |
Why?
| Anemia | 1 | 2016 | 84 | 0.130 |
Why?
| Risk Reduction Behavior | 1 | 2016 | 70 | 0.130 |
Why?
| Pneumonia | 1 | 2016 | 129 | 0.130 |
Why?
| Injections, Epidural | 1 | 2015 | 10 | 0.130 |
Why?
| Chronic Disease | 1 | 2018 | 614 | 0.130 |
Why?
| Ambulatory Care Facilities | 1 | 2016 | 136 | 0.130 |
Why?
| Liposomes | 1 | 2015 | 53 | 0.130 |
Why?
| Arthroplasty, Replacement, Ankle | 1 | 2014 | 3 | 0.130 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 142 | 0.120 |
Why?
| Multivariate Analysis | 1 | 2016 | 643 | 0.120 |
Why?
| Anesthetics, Local | 1 | 2015 | 74 | 0.120 |
Why?
| Follow-Up Studies | 3 | 2020 | 2387 | 0.120 |
Why?
| Tobacco Smoke Pollution | 1 | 2014 | 56 | 0.120 |
Why?
| Drug Overdose | 1 | 2016 | 154 | 0.120 |
Why?
| Delivery of Health Care | 1 | 2017 | 327 | 0.120 |
Why?
| Age Factors | 1 | 2017 | 1198 | 0.120 |
Why?
| Smoking | 1 | 2018 | 556 | 0.120 |
Why?
| Arthropod Proteins | 1 | 2013 | 1 | 0.120 |
Why?
| Antigens, Dermatophagoides | 1 | 2013 | 3 | 0.120 |
Why?
| Bacteria | 1 | 2015 | 258 | 0.110 |
Why?
| Diabetes Mellitus | 1 | 2017 | 309 | 0.110 |
Why?
| Humeral Fractures | 1 | 1992 | 10 | 0.110 |
Why?
| Joint Prosthesis | 1 | 1992 | 14 | 0.110 |
Why?
| Cysteine Endopeptidases | 1 | 2013 | 75 | 0.110 |
Why?
| Patient Positioning | 1 | 2013 | 35 | 0.110 |
Why?
| Environmental Monitoring | 1 | 2013 | 71 | 0.110 |
Why?
| Carpal Bones | 1 | 1992 | 2 | 0.110 |
Why?
| Synostosis | 1 | 1992 | 2 | 0.110 |
Why?
| Venous Thrombosis | 1 | 2014 | 102 | 0.110 |
Why?
| Pulmonary Embolism | 1 | 2014 | 106 | 0.110 |
Why?
| Diseases in Twins | 1 | 1992 | 15 | 0.110 |
Why?
| Glycoproteins | 1 | 2013 | 132 | 0.110 |
Why?
| Mass Screening | 1 | 2016 | 370 | 0.110 |
Why?
| Child, Preschool | 7 | 2016 | 4147 | 0.110 |
Why?
| Ambulatory Care | 1 | 2014 | 230 | 0.110 |
Why?
| Shoulder Joint | 1 | 1992 | 71 | 0.100 |
Why?
| Arm Injuries | 1 | 1991 | 15 | 0.100 |
Why?
| Fungal Proteins | 1 | 2013 | 134 | 0.100 |
Why?
| Socioeconomic Factors | 3 | 2023 | 642 | 0.100 |
Why?
| Acute Kidney Injury | 1 | 2016 | 403 | 0.100 |
Why?
| Child | 8 | 2020 | 7341 | 0.100 |
Why?
| Lidocaine | 1 | 1991 | 48 | 0.100 |
Why?
| Immunoglobulin E | 2 | 2016 | 93 | 0.100 |
Why?
| Nerve Block | 1 | 1991 | 37 | 0.100 |
Why?
| Immunoglobulin A | 2 | 2021 | 54 | 0.100 |
Why?
| Antigens, Viral | 2 | 2021 | 58 | 0.100 |
Why?
| Mycotoxins | 2 | 2008 | 12 | 0.100 |
Why?
| Immunoglobulin M | 2 | 2021 | 65 | 0.100 |
Why?
| Mental Disorders | 1 | 2016 | 451 | 0.100 |
Why?
| Stroke | 1 | 2016 | 526 | 0.100 |
Why?
| Aging | 1 | 1996 | 784 | 0.100 |
Why?
| Cohort Studies | 3 | 2021 | 1543 | 0.090 |
Why?
| Protein Binding | 2 | 2021 | 736 | 0.080 |
Why?
| Kinetics | 2 | 2021 | 692 | 0.080 |
Why?
| Obesity | 1 | 2017 | 1202 | 0.080 |
Why?
| Phylogeny | 2 | 2021 | 269 | 0.080 |
Why?
| Environmental Illness | 1 | 2007 | 1 | 0.080 |
Why?
| Sick Building Syndrome | 1 | 2007 | 1 | 0.080 |
Why?
| Propensity Score | 2 | 2017 | 137 | 0.070 |
Why?
| Inflammation | 2 | 2022 | 674 | 0.070 |
Why?
| Air | 1 | 2005 | 26 | 0.070 |
Why?
| Hospitalization | 2 | 2020 | 705 | 0.070 |
Why?
| Kansas | 2 | 2014 | 25 | 0.060 |
Why?
| Practice Guidelines as Topic | 2 | 2020 | 492 | 0.060 |
Why?
| Animals | 4 | 2023 | 14385 | 0.060 |
Why?
| Arkansas | 2 | 2019 | 2100 | 0.060 |
Why?
| Health Status | 1 | 2005 | 368 | 0.060 |
Why?
| Health Status Indicators | 1 | 2002 | 94 | 0.050 |
Why?
| Benchmarking | 1 | 2022 | 73 | 0.050 |
Why?
| Chromium | 1 | 2021 | 5 | 0.050 |
Why?
| New York | 1 | 2021 | 50 | 0.050 |
Why?
| Femur Neck | 1 | 2021 | 8 | 0.050 |
Why?
| Immune Evasion | 1 | 2021 | 12 | 0.050 |
Why?
| Muscles | 1 | 2022 | 114 | 0.050 |
Why?
| Antigen-Antibody Reactions | 1 | 2021 | 18 | 0.050 |
Why?
| Cobalt | 1 | 2021 | 19 | 0.050 |
Why?
| Leg | 1 | 2022 | 130 | 0.050 |
Why?
| Back | 1 | 2021 | 6 | 0.050 |
Why?
| Antigen-Antibody Complex | 1 | 2021 | 39 | 0.050 |
Why?
| Protein Structure, Quaternary | 1 | 2021 | 28 | 0.050 |
Why?
| Immunoglobulin Variable Region | 1 | 2021 | 33 | 0.050 |
Why?
| Epitopes, B-Lymphocyte | 1 | 2021 | 4 | 0.050 |
Why?
| Somatic Hypermutation, Immunoglobulin | 1 | 2021 | 4 | 0.050 |
Why?
| Immunization, Secondary | 1 | 2021 | 17 | 0.050 |
Why?
| Immune Sera | 1 | 2021 | 24 | 0.050 |
Why?
| Fibrosis | 1 | 2022 | 208 | 0.050 |
Why?
| Torso | 1 | 2021 | 25 | 0.050 |
Why?
| Receptors, Antigen, B-Cell | 1 | 2021 | 9 | 0.050 |
Why?
| HLA Antigens | 1 | 2021 | 55 | 0.050 |
Why?
| Fracture Fixation, Internal | 1 | 2021 | 46 | 0.050 |
Why?
| Directed Molecular Evolution | 1 | 2020 | 1 | 0.050 |
Why?
| Tibia | 1 | 2021 | 117 | 0.050 |
Why?
| Protein Multimerization | 1 | 2021 | 54 | 0.050 |
Why?
| Protein Engineering | 1 | 2020 | 21 | 0.050 |
Why?
| Genome, Viral | 1 | 2021 | 100 | 0.050 |
Why?
| Protein Conformation | 1 | 2021 | 226 | 0.050 |
Why?
| Crystallography, X-Ray | 1 | 2021 | 178 | 0.050 |
Why?
| Femur Head | 1 | 2020 | 27 | 0.050 |
Why?
| Mice | 2 | 2023 | 6413 | 0.050 |
Why?
| Fluorescent Antibody Technique | 1 | 2021 | 141 | 0.050 |
Why?
| Cefazolin | 1 | 2020 | 11 | 0.050 |
Why?
| North America | 1 | 2020 | 68 | 0.050 |
Why?
| Bone Transplantation | 1 | 2020 | 55 | 0.050 |
Why?
| Penicillins | 1 | 2020 | 29 | 0.050 |
Why?
| Antibody Specificity | 1 | 2020 | 48 | 0.050 |
Why?
| Virulence | 1 | 2021 | 194 | 0.050 |
Why?
| Sequence Analysis, RNA | 1 | 2021 | 107 | 0.050 |
Why?
| Cricetinae | 1 | 2020 | 209 | 0.050 |
Why?
| Immunization | 1 | 2021 | 95 | 0.050 |
Why?
| Viral Vaccines | 1 | 2020 | 14 | 0.050 |
Why?
| Salvage Therapy | 1 | 2021 | 145 | 0.050 |
Why?
| Binding Sites | 1 | 2021 | 440 | 0.050 |
Why?
| Structure-Activity Relationship | 1 | 2021 | 423 | 0.050 |
Why?
| Operating Rooms | 1 | 2020 | 40 | 0.050 |
Why?
| Mice, Inbred BALB C | 1 | 2021 | 368 | 0.050 |
Why?
| Patella | 1 | 2019 | 17 | 0.050 |
Why?
| Aftercare | 1 | 2020 | 81 | 0.040 |
Why?
| Heel | 1 | 2019 | 7 | 0.040 |
Why?
| Shoes | 1 | 2019 | 13 | 0.040 |
Why?
| Infection Control | 1 | 2020 | 57 | 0.040 |
Why?
| Sutures | 1 | 2019 | 45 | 0.040 |
Why?
| Time and Motion Studies | 1 | 2019 | 16 | 0.040 |
Why?
| Sports Equipment | 1 | 2019 | 9 | 0.040 |
Why?
| Intestines | 1 | 2021 | 204 | 0.040 |
Why?
| Disability Evaluation | 1 | 2019 | 103 | 0.040 |
Why?
| Physical Examination | 1 | 2019 | 99 | 0.040 |
Why?
| Software | 1 | 2021 | 296 | 0.040 |
Why?
| Telephone | 1 | 2019 | 75 | 0.040 |
Why?
| Electronic Health Records | 1 | 2021 | 206 | 0.040 |
Why?
| Biopsy | 1 | 2021 | 692 | 0.040 |
Why?
| Quality Assurance, Health Care | 1 | 2019 | 164 | 0.040 |
Why?
| Referral and Consultation | 1 | 2020 | 307 | 0.040 |
Why?
| Morphine | 1 | 2018 | 96 | 0.040 |
Why?
| Molecular Weight | 1 | 2017 | 100 | 0.040 |
Why?
| Linear Models | 1 | 2018 | 309 | 0.040 |
Why?
| Prospective Studies | 2 | 2002 | 2604 | 0.040 |
Why?
| Macadamia | 1 | 2016 | 1 | 0.040 |
Why?
| Muscle, Skeletal | 1 | 2022 | 847 | 0.030 |
Why?
| Protein Array Analysis | 1 | 2015 | 28 | 0.030 |
Why?
| Probability | 1 | 2016 | 176 | 0.030 |
Why?
| Genes, Bacterial | 1 | 2015 | 67 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2021 | 1138 | 0.030 |
Why?
| Case-Control Studies | 1 | 2019 | 1228 | 0.030 |
Why?
| RNA, Ribosomal, 16S | 1 | 2015 | 106 | 0.030 |
Why?
| Quality of Life | 1 | 2022 | 922 | 0.030 |
Why?
| Corrosion | 1 | 2014 | 4 | 0.030 |
Why?
| Ions | 1 | 2014 | 38 | 0.030 |
Why?
| Urban Population | 1 | 2015 | 182 | 0.030 |
Why?
| Emergency Service, Hospital | 1 | 2019 | 539 | 0.030 |
Why?
| Metals | 1 | 2014 | 44 | 0.030 |
Why?
| Prevalence | 2 | 2014 | 1025 | 0.030 |
Why?
| Twins, Monozygotic | 1 | 1992 | 17 | 0.030 |
Why?
| Thrombophlebitis | 1 | 1992 | 28 | 0.030 |
Why?
| Arthritis, Rheumatoid | 1 | 1992 | 130 | 0.030 |
Why?
| Injections, Intravenous | 1 | 1991 | 148 | 0.030 |
Why?
| Vena Cava Filters | 1 | 1992 | 38 | 0.030 |
Why?
| Prognosis | 1 | 1996 | 2118 | 0.020 |
Why?
| Pelvic Bones | 1 | 1990 | 11 | 0.020 |
Why?
| Dextrans | 1 | 1990 | 20 | 0.020 |
Why?
| Algorithms | 1 | 2014 | 697 | 0.020 |
Why?
| Hip Fractures | 1 | 1990 | 53 | 0.020 |
Why?
| Thromboembolism | 1 | 1990 | 56 | 0.020 |
Why?
| Leg Injuries | 1 | 1989 | 14 | 0.020 |
Why?
| Risk Assessment | 1 | 2014 | 1361 | 0.020 |
Why?
| Irritants | 1 | 2008 | 1 | 0.020 |
Why?
| Ergosterol | 1 | 2008 | 8 | 0.020 |
Why?
| Glucans | 1 | 2008 | 8 | 0.020 |
Why?
| Surgical Flaps | 1 | 1989 | 135 | 0.020 |
Why?
| Magnetic Resonance Imaging | 1 | 2014 | 1604 | 0.020 |
Why?
| Phlebography | 2 | 1992 | 70 | 0.010 |
Why?
| Polyethylenes | 1 | 1994 | 13 | 0.010 |
Why?
| Prothrombin Time | 1 | 1992 | 19 | 0.010 |
Why?
| Drug Monitoring | 1 | 1992 | 85 | 0.010 |
Why?
| Urogenital System | 1 | 1990 | 5 | 0.010 |
Why?
| Warfarin | 1 | 1992 | 87 | 0.010 |
Why?
| Multiple Trauma | 1 | 1990 | 34 | 0.010 |
Why?
| Femoral Neck Fractures | 1 | 1990 | 7 | 0.010 |
Why?
| Injury Severity Score | 1 | 1990 | 178 | 0.010 |
Why?
| Combined Modality Therapy | 1 | 1992 | 692 | 0.010 |
Why?
|
|
Barnes's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|